Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics

Illumina, Inc. (NASDAQ: ILMN) announced new customer breakthroughs in oncology powered by Illumina's spatial transcriptomics, ...
TMCnet

Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility

40% increase in output to 35 billion reads, up to Q70 quality scores, improved turnaround time, and staggered starts are ...

Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected Multiomics

Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a suite o ...
The Scientist

SPT Labtech to collaborate with Illumina to develop automated platform supporting genomics in decentralized healthcare settings

Builds on success of existing partnership including development of automated library preparation methods on SPT Labtech’s ...
Seeking Alpha

Illumina launches its first product enabling long- and short-read sequencing on one instrument

Early customer data reinforces accuracy and flexibility of novel long-read technology, unlocking access to challenging, low DNA input samples SAN DIEGO, March 14, 2023 /PRNewswire/ -- Illumina Inc.

Scrappy San Diego startup goes toe-to-toe with gene-sequencing giant Illumina

Element Biosciences created a high-throughput benchtop device that can deliver a whole genome for $100 – half the price of ...